Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Sunday, August 30, 2015 10:10:46 AM
bullish
close > 1 and average volume > 100k
bullish divergence breakout
double bottom
Theravance Biopharma, Inc.
Ugland House
South Church Street
George Town, KY1-1104
Cayman Islands
Phone: 650-808-6000
Website: http://www.theravance.com
Investors: http://investor.theravance.com/index.cfm
Theravance Biopharma, Inc. engages in the research and development activities focusing on the diseases of the lung and gastrointestinal tract, and infectious diseases, as well as on the acute care setting markets. The company offers VIBATIV, a bactericidal, once-daily injectable antibiotic to treat patients with infections due to Staphylococcus aureus and other Gram-positive bacteria. The company's TD-4208, an investigational long-acting muscarinic antagonist, which has completed Phase IIb study for the treatment of chronic obstructive pulmonary disease; and Axelopran, an investigational, once-daily, and oral peripherally active mu opioid receptor antagonist that is in Phase II clinical trial for opioid-induced constipation. It also offers Velusetrag, an oral and investigational medicine, which has completed first Phase II study for gastrointestinal motility disorders. The company focuses on various drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol; the MABA program, as monotherapy; and in combination with other therapeutically active components, such as an inhaled corticosteroid. Theravance Biopharma, Inc. is incorporated in 2013 and is based in George Town, the Cayman Islands.
## source: finance.yahoo.com
Fri, 28 Aug 2015 20:40:14 GMT ~ THERAVANCE BIOPHARMA, INC. Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statements
read full: http://biz.yahoo.com/e/150828/tbph8-k_a.html
*********************************************************
Thu, 27 Aug 2015 20:54:01 GMT ~ Theravance Biopharma to Present at the Baird 2015 Healthcare Conference
[at noodls] - August 27, 2015 DUBLIN, IRELAND -- (Marketwired) -- 08/27/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that Rick E Winningham, Chairman and Chief Executive Officer and other members ...
read full: http://www.noodls.com/view/609191CD7421533E3C9DB7BBB33B028E6B0488CC
*********************************************************
Thu, 27 Aug 2015 20:30:00 GMT ~ Theravance Biopharma to Present at the Baird 2015 Healthcare Conference
[Marketwired] - Theravance Biopharma, Inc. announced today that Rick E Winningham, Chairman and Chief Executive Officer and other members of the management team will participate in a fireside chat at the Baird 2015 Healthcare ...
read full: http://finance.yahoo.com/news/theravance-biopharma-present-baird-2015-203000731.html
*********************************************************
Thu, 27 Aug 2015 17:04:19 GMT ~ THERAVANCE BIOPHARMA, INC. Financials
read full: http://finance.yahoo.com/q/is?s=tbph
*********************************************************
Wed, 19 Aug 2015 12:37:12 GMT ~ Theravance Biopharma (TBPH) in Focus: Stock Rises 5.9%
read full: http://finance.yahoo.com/news/theravance-biopharma-tbph-focus-stock-123712233.html
*********************************************************
$TBPH charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$TBPH company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/TBPH/company-info
Ticker: $TBPH
OTC Market Place: Not Available
CIK code: not found
Company name: Theravance Biopharma, Inc.
Incorporated In:
$TBPH share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$TBPH extra dd links
Company name: Theravance Biopharma, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=TBPH+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=TBPH+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=TBPH+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/TBPH/news - http://finance.yahoo.com/q/h?s=TBPH+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/TBPH/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/TBPH/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=TBPH+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/TBPH
DTCC (dtcc.com): http://search2.dtcc.com/?q=Theravance+Biopharma%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Theravance+Biopharma%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Theravance+Biopharma%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/TBPH
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/TBPH/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/TBPH/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=TBPH&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=TBPH
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/TBPH/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=TBPH+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=TBPH+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=TBPH
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=TBPH
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=TBPH+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/TBPH/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=TBPH+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/TBPH.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=TBPH
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/TBPH/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/TBPH
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/TBPH
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/TBPH:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=TBPH
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=TBPH
$TBPH DD Notes ~ http://www.ddnotesmaker.com/TBPH
Recent TBPH News
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/24/2024 08:44:13 PM
- Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024 • PR Newswire (US) • 10/24/2024 10:00:00 AM
- Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease • PR Newswire (US) • 10/18/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 10:05:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 10:02:13 AM
- Theravance Biopharma to Participate in an Upcoming Investor Conference • PR Newswire (US) • 08/27/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 12:07:49 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 12:06:31 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 12:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 12:03:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 10:02:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:57:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 08:16:13 PM
- Theravance Biopharma, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update • PR Newswire (US) • 08/05/2024 08:05:00 PM
- Theravance Biopharma to Participate in an Upcoming Investor Conference • PR Newswire (US) • 07/25/2024 10:00:00 AM
- Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024 • PR Newswire (US) • 07/22/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 10:15:14 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 06/11/2024 08:17:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 10:08:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 10:06:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 10:04:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 10:02:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 10:26:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:13:20 PM
- Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update • PR Newswire (US) • 05/13/2024 08:05:00 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM